Ironwood Pharmaceuticals | IRWD - Assets


Ironwood Pharmaceuticals reported $396.06M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Acadia Pharmaceuticals USD 1.33B 105.22M Sep/2025
Agios Pharmaceuticals USD 1.3B 88.48M Dec/2025
Akebia Therapeutics USD 364.15M 18.56M Sep/2025
Almirall EUR 2.34B 29.21M Dec/2025
Alnylam Pharmaceuticals USD 4.97B 114.67M Dec/2025
Amarin USD 659.81M 10.31M Sep/2025
Ardelyx USD 486.17M 19.4M Sep/2025
Astellas Pharma JPY 3.6T 153.62B Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
Charles River Laboratories USD 7.14B 378.39M Dec/2025
Coherus Biosciences USD 516.52M 77.05M Sep/2025
Emergent BioSolutions USD 1.82B 69.9M Dec/2023
Esperion Therapeutics USD 364.02M 16.93M Sep/2025
Exact Sciences USD 5.86B 39.38M Dec/2025
Halozyme Therapeutics USD 2.53B 304.09M Dec/2025
Incyte USD 6.96B 627.62M Dec/2025
Ironwood Pharmaceuticals USD 396.06M 53.12M Sep/2025
Karyopharm Therapeutics USD 96.23M 8.65M Sep/2025
Lexicon Pharmaceuticals USD 225.58M 72.09M Jun/2025
MacroGenics USD 270.76M 25.34M Sep/2025
Moderna USD 12.34B 203M Dec/2025
Myriad Genetics USD 728.1M 50.8M Sep/2025
Pacira USD 1.3B 239.68M Sep/2025
PTC Therapeutics USD 2.9B 255.07M Dec/2025
Puma Biotechnology USD 202.86M 7.95M Sep/2025
Sarepta Therapeutics USD 3.49B 186.38M Sep/2025
Takeda JPY 15.41T 938.47B Dec/2025
Ultragenyx Pharmaceutical USD 1.53B 341.56M Dec/2025
Vanda Pharmaceuticals USD 488.95M 112.19M Dec/2025